Pharmaron revenue increased from ¥2.9 billion in 2018 to ¥3.8 billion in 2019, a (29.2%) increase.

Annual Revenue (¥)

Pharmaron revenue was ¥3.76 b in FY, 2019 which is a (29.2%) year over year increase from the previous period.

FY, 2017FY, 2018FY, 2019
Revenue¥2.29 b¥2.91 b¥3.76 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Pharmaron revenue breakdown by business segment: 63.3% from Laboratory Services, 24.0% from CMC Services, 12.1% from Clinical Development Services and 0.5% from Other

Pharmaron revenue breakdown by geographic segment: 23.1% from Europe, 12.7% from Mainland China , 58.8% from North America and 5.3% from Other

FY, 2018FY, 2019
Laboratory Services1.9 b2.38 b
CMC Services645.82 m901.58 m
Clinical Development Services347.5 m456.27 m
Other 19.04 m19.81 m
FY, 2018FY, 2019
Europe631.71 m869.54 m
Asia (except Mainland China)141.53 m149.94 m
Mainland China 297.83 m478.4 m
North America1.81 b2.21 b
Others27.38 m50.59 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu